223 related articles for article (PubMed ID: 17101941)
1. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.
Chan PS; Chow T; Kereiakes D; Schloss EJ; Waller T; Eagle K; Hayward RA; Vijan S
Arch Intern Med; 2006 Nov; 166(20):2228-33. PubMed ID: 17101941
[TBL] [Abstract][Full Text] [Related]
2. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
[TBL] [Abstract][Full Text] [Related]
3. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.
Chan PS; Hayward RA
J Am Coll Cardiol; 2005 May; 45(9):1474-81. PubMed ID: 15862422
[TBL] [Abstract][Full Text] [Related]
4. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
[TBL] [Abstract][Full Text] [Related]
5. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
[TBL] [Abstract][Full Text] [Related]
6. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
[TBL] [Abstract][Full Text] [Related]
8. Fragmented QRS and mortality risk in patients with left ventricular dysfunction.
Cheema A; Khalid A; Wimmer A; Bartone C; Chow T; Spertus JA; Chan PS
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):339-44. PubMed ID: 20511537
[TBL] [Abstract][Full Text] [Related]
9. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
Chow T; Saghir S; Bartone C; Goebel M; Schneider J; Booth T; Chan PS
Am J Cardiol; 2007 Aug; 100(4):598-604. PubMed ID: 17697813
[TBL] [Abstract][Full Text] [Related]
12. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.
Ermis C; Lurie KG; Zhu AX; Collins J; Vanheel L; Sakaguchi S; Lu F; Pham S; Benditt DG
J Cardiovasc Electrophysiol; 2004 Aug; 15(8):862-6. PubMed ID: 15333075
[TBL] [Abstract][Full Text] [Related]
13. Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation.
Thibodeau JB; Pillarisetti J; Khumri TM; Jones PG; Main ML
Am J Cardiol; 2008 Mar; 101(6):861-4. PubMed ID: 18328854
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
15. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Dickinson MG; Ip JH; Olshansky B; Hellkamp AS; Anderson J; Poole JE; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2007 Apr; 153(4):573-8. PubMed ID: 17383296
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
Smit MD; Van Dessel PF; Rienstra M; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Veldhuisen DJ; Van Gelder IC
Europace; 2006 Aug; 8(8):566-72. PubMed ID: 16864611
[TBL] [Abstract][Full Text] [Related]
17. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
18. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.
Ng AC; Bertini M; Borleffs CJ; Delgado V; Boersma E; Piers SR; Thijssen J; Nucifora G; Shanks M; Ewe SH; Biffi M; van de Veire NR; Leung DY; Schalij MJ; Bax JJ
Am J Cardiol; 2010 Dec; 106(11):1566-73. PubMed ID: 21094356
[TBL] [Abstract][Full Text] [Related]
19. Detectable troponin levels predict poor prognosis in patients with left ventricular dysfunction undergoing internal defibrillator implantation.
Sonel AF; Shalaby A; McConnell JP; Czarnecki T; Hogen S; Zahid M; Amidi M
Pacing Clin Electrophysiol; 2007 Jul; 30(7):839-44. PubMed ID: 17584264
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
